Diagnostic Medical Systems

As of June 30, 2026, Diagnostic Medical Systems carries a market capitalization of 31.81M, placing it among publicly traded companies globally. Its enterprise value stands at 48.19M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Diagnostic Medical Systems has 25.86M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Diagnostic Medical Systems maintains a current ratio of 1.61, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 19, 2026, Diagnostic Medical Systems's stock has declined approximately 36.54% over the past 52 weeks. The 50-day moving average sits at 1.17, while the 200-day moving average is 1.23.

As of June 30, 2026, Diagnostic Medical Systems holds 4.56M in cash and equivalents against 19.29M in total debt, resulting in a net debt position of 11.46M. Total book value stands at 19.60M, with working capital of 13.42M providing operational flexibility.

Diagnostic Medical Systems's most recent stock split took place on July 21, 2016 with a 10:1 split ratio.